Company context
Sidekick Health prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Sidekick Health is a global digital therapeutics (DTx) company that specializes in developing AI-powered, cloud-based care management solutions. Founded by medical doctors, the company leverages behavioral science, gamification, and clinical expertise to help patients manage chronic and lifestyle-related conditions. By operating a B2B2C model, Sidekick partners with major pharmaceutical companies, healthcare providers, and insurers to deliver personalized, evidence-based digital interventions that extend care beyond the traditional clinical setting. In recent years, Sidekick has aggressively expanded its footprint in the regulated digital health market through strategic acquisitions, including the German company aidhere and the digital health platform PINK!. These moves have allowed the company to offer a robust portfolio of prescription digital therapeutics (PDT) and integrated care coordination tools. With a strong focus on clinical outcomes, the company supports over 20 therapeutic areas, including oncology, cardiometabolic health, and inflammatory conditions, while maintaining a commitment to making healthcare more equitable and efficient.
Mission: To digitize healthcare, making it more impactful, equitable, and efficient through its AI-powered, cloud-based platform.
Founded
2013
Headquarters
Reykjavik, Iceland
Employees
200-500
Industry
Digital Therapeutics
Mission-driven work that directly impacts patient health outcomes.
Opportunity to work at the intersection of medicine, behavioral science, and cutting-edge technology.
Global presence with a collaborative, multi-disciplinary team environment.
Revenue
Undisclosed
Funding
Venture-backed
CEO
Dr. Tryggvi Thorgeirsson
Rapid growth and acquisitions can lead to organizational shifts and integration challenges.
Navigating complex regulatory environments for digital therapeutics can be demanding.